Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis

Fig. 3

The Kaplan-Meier curve of overall survival of PDAC patients after PSM. A.Comparison of OS between the neoadjuvant radiotherapy group and the only surgery group for T1-3N0M0 stage (P = 0.176); B. Comparison of OS between the neoadjuvant radiotherapy group and the adjuvant radiotherapy group for T1-3N0M0 stage (P = 0.125); C. Comparison of OS between the neoadjuvant radiotherapy group and the surgery plus chemotherapy group for T1-3N0M0 stage (P = 0.025); D. Comparison of OS between the neoadjuvant radiotherapy group and the only surgery group for T1-3N + M0 stage (P = 0.036); E. Comparison of OS between the neoadjuvant radiotherapy group and the adjuvant radiotherapy group for T1-3N + M0 stage (P = 0.022); F. Comparison of OS between the neoadjuvant radiotherapy group and the surgery plus chemotherapy group for T1-3N + M0 stage (P = 0.541); G. Comparison of OS between the neoadjuvant radiotherapy group and the only surgery group for T4 stage (P < 0.001); H. Comparison of OS between the neoadjuvant radiotherapy group and the adjuvant radiotherapy group for T4 stage (P = 0.002); I. Comparison of OS between the neoadjuvant radiotherapy group and the surgery plus chemotherapy group for T4 stage (P = 0.028).

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us